Abstract
Postmenopausal women with osteopenia comparing with osteoporosis also has high risk of fractures.Among this group of people,the criteria for initiation of intervention with pharmacotherapy is not merely according to bone mineral density(BMD),but considering of risk factors for fractures.Various medicines such as bisphosphonate,selective estrogen receptor modulator,strontium ranelate can increase BMD and decrease the risk of fractures in this crowd. Key words: Osteopenia; Postmenopausal women; Pharmaeotherapy; Osteoporosis(Int J Endocrinol Metab,2009,29:181-183)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have